# NATCO Pharma Limited – FDA Inspection, Jun 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d
Source feed: FDA_Inspections

> FDA inspection 1273711 of NATCO Pharma Limited, June 19, 2025. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273711
- Company Name: NATCO Pharma Limited
- Inspection Date: 2025-06-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- [FDA Inspection 1220533 - 2023-10-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/490eaf04-f2ac-48ef-96c9-2879ca06696c)
- FDA Inspection 1137171 - 2019-06-24
- [FDA Inspection 1095772 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2)
- [FDA Inspection 1011854 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351)
- FDA Inspection 880454 - 2014-05-23

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)

Company: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
